oral semaglutide oasis 4.2 mg
Master Semaglutide Dose‑Response to Maximize Weight Loss
The 4.2 mg oral semaglutide dose delivers up to 15% more BMI reduction than the 3 mg starting dose, as shown in the OASIS trial. This finding suggests a dose-response advantage that can reshape obesity treatment protocols. Medical Disclaimer: This article is for informational purposes only and does not